Luo Ying 4
4 · GYRE THERAPEUTICS, INC. · Filed Aug 16, 2024
Insider Transaction Report
Form 4
Luo Ying
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-14+26,000→ 26,000 totalExercise: $9.98Exp: 2034-08-14→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.